Valuation: Kim Forest Enterprise Co., Ltd.

Market Cap 81Cr 2.52Cr 2.18Cr 2.04Cr 1.87Cr 3.53Cr 239.66Cr 3.58Cr 24Cr 9.39Cr 119.74Cr 9.45Cr 9.24Cr 398.54Cr P/E 2024
-7.91x
P/E 2025 -7.34x
Enterprise Value 107.23Cr 3.32Cr 2.88Cr 2.7Cr 2.47Cr 4.66Cr 316.41Cr 4.72Cr 32Cr 12Cr 158.09Cr 12Cr 12Cr 526.19Cr EV / Sales 2024
2.86x
EV / Sales 2025 2.43x
Free-Float
43.95%
Yield 2024 *
-
Yield 2025 -
1 day+3.46%
1 week+0.37%
Current month+0.75%
1 month-13.50%
3 months+5.08%
6 months-24.44%
Current year-24.01%
1 week 11.75
Extreme 11.75
14.05
1 month 11.75
Extreme 11.75
16.45
Current year 11.4
Extreme 11.4
18.5
1 year 11.4
Extreme 11.4
26.45
3 years 11.4
Extreme 11.4
48.1
5 years 11.4
Extreme 11.4
50.38
10 years 8.27
Extreme 8.27329
122.57
Manager TitleAgeSince
Chief Executive Officer - 01/07/2005
Director of Finance/CFO - 02/12/2013
Chief Tech/Sci/R&D Officer - 01/11/2016
Director TitleAgeSince
Chairman - 22/09/2014
Director/Board Member - 28/07/2004
Director/Board Member - 29/06/2016
Change 5-day change 1-year change 3-year change Capi.($)
+3.46%+0.37%-25.69%-71.64% 2.43Cr
+0.48%-2.11%-42.27%-43.89% 61Cr
-1.25%+20.68%+126.61% - 40Cr
+2.82%+27.40%-31.27%+12.01% 12Cr
+5.74%+1.18%-1.15%+59.26% 9.49Cr
Average +2.25%+3.96%+5.25%-11.07% 24.97Cr
Weighted average by Cap. +0.61%+3.73%+16.50%-25.10%

Financials

2024 2025
Net sales 50Cr 1.55Cr 1.35Cr 1.26Cr 1.15Cr 2.18Cr 147.99Cr 2.21Cr 15Cr 5.8Cr 74Cr 5.83Cr 5.71Cr 246.11Cr 55Cr 1.7Cr 1.48Cr 1.38Cr 1.26Cr 2.39Cr 162.04Cr 2.42Cr 16Cr 6.35Cr 81Cr 6.39Cr 6.25Cr 269.48Cr
Net income -16Cr -49.53L -42.98L -40.24L -36.81L -69.5L -47Cr -70.41L -4.71Cr -1.85Cr -24Cr -1.86Cr -1.82Cr -78Cr -15Cr -45.37L -39.37L -36.86L -33.72L -63.66L -43Cr -64.49L -4.31Cr -1.69Cr -22Cr -1.7Cr -1.67Cr -72Cr
Net Debt 15Cr 45.38L 39.38L 36.88L 33.73L 63.68L 43Cr 64.51L 4.31Cr 1.69Cr 22Cr 1.7Cr 1.67Cr 72Cr 26Cr 80.58L 69.93L 65.48L 59.9L 1.13Cr 77Cr 1.15Cr 7.66Cr 3.01Cr 38Cr 3.03Cr 2.96Cr 127.65Cr
Logo Kim Forest Enterprise Co., Ltd.
KIM FOREST ENTERPRISE CO., LTD. is a Taiwan-based company mainly engaged in sale of biomedical products and provision of genetic testing and analysis services. The Company operates through two segments. The Biomedical Experiment Products segment is engaged in provision of laboratory equipment, reagents, supplies and equipment maintenance services. Main products include filter type microplate spectrophotometer, polymerase chain reaction (PCR) molecular biology experiment related equipment and reagents, equipment and reagents for separating cell, protein and nucleic acids, rapid DNA detection reagent and others. The Biotechnology and Genetic Testing segment is engaged in provision of whole genome sequencing (WGS) and whole exome sequencing(WES) tumor analysis services, RNA sequencing analysis, and new drug development system and check services.
Employees
-
Date Price Change Volume
06/26/06 NT$13.45 +3.46% 5,301
05/26/05 NT$13.00 -1.14% 25,052
04/26/04 NT$13.15 +0.77% 44,505
03/26/03 NT$13.05 -2.25% 17,617
31/26/31 NT$13.35 +1.14% 43,035
  1. Stock Market
  2. Stocks
  3. 6645 Stock